Ursodeoxycholic acid is a medication used for the treatment of liver diseases such as primary biliary cholangitis. It works by dissolving gallstones and protecting the liver from damage. The demand for ursodeoxycholic acid is increasing with rise in cases of liver diseases. It helps dissolve cholesterol gallstones and prevent their formation. It has advantages over other medications for treatment of liver diseases as it does not cause major side effects.
The global Ursodeoxycholic Acid Market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of ursodeoxycholic acid for treatment of liver diseases is a major trend boosting the market growth. As per a recent study by Cliver Foundation, over 200 million people suffer from chronic liver diseases globally. To treat conditions such as primary biliary cholangitis, ursodeoxycholic acid is widely used around the world. The effectiveness of ursodeoxycholic acid in dissolution of gallstones and preventing their formation has increased its preference over other medications. This widespread usage has accelerated the growth of ursodeoxycholic acid market over the forecast period.
Segment Analysis
The global ursodeoxycholic acid market is dominated by the pharmaceutical-grade ursodeoxycholic acid segment. Pharmaceutical-grade is the purest form suitable for human consumption and manufacturing pharmaceutical formulations. It accounts for over 60% of the total market share owing to its purity and suitability for treating health conditions such as gallstones, primary biliary cholangitis, and non-alcoholic fatty liver disease.
Key Takeaways
The Global Ursodeoxycholic Acid Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market size is estimated at US$ 640.45 Mn in 2023 and projected to reach above US$ 860 Mn, witnessing a CAGR of 3.5% during the same period.
Regional analysis:
North America holds the largest market share currently and is expected to maintain its dominance through 2030. Higher awareness regarding hepatic health and increasing cases of liver disorders are primarily driving the North American market. Asia Pacific is projected to grow at the fastest rate during the forecast timeline owing to rising healthcare expenditure, growing middle-class population and demand for alternative therapies.
Key players:
Key players operating in the ursodeoxycholic acid market are Fender Musical Instruments Corporation, Gibson Brands, Ernie Ball Inc., GHS Strings, C. F. Martin & Company Inc., Dunlop Manufacturing, Inc., Dean Markley USA, Inc., Kistron Co., Ltd., Rotosound Manufacturing Ltd., and DR Handmade Strings. Fender and Gibson hold a significant share in the guitar strings segment while Ernie Ball is a prominent player for acoustic guitar strings.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/ursodeoxycholic-acid-market-growth-and-forecasts-analysis/
Explore more trending article on this topic -
